Surgical Skin Preparation Clinical Trial
Official title:
Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZuraPrep
The objective of the study is to demonstrate the antimicrobial efficacy of the Zurex Preoperative Prep (ZuraPrep - clear) on skin flora of the abdomen and inguinal regions of human subjects.
The primary objective of this study is to measure the antimicrobial effectiveness of a single investigational test article, ZuraPrep™ as specified by the Healthcare Antiseptics, Topical Antimicrobial Drug Products Final Rule of December 20, 2017. The treatments will be ZuraPrep™ as the investigational test article, ChloraPrep® as an active control, and ZuraPrep™ Vehicle as a negative control. For efficacy at 30 seconds post-prep, the test article should be superior to the negative control using a margin of 1.2 log10 CFU/cm2 and non-inferior to the active control using a margin of 0.5 log10 CFU/cm2. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03681990 -
In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage Area
|
Phase 2 | |
| Completed |
NCT04756154 -
Efficacy Study of Patient Preoperative Preps In-vivo
|
Phase 3 | |
| Completed |
NCT02831998 -
In-vivo Efficacy of Patient Preoperative Prep
|
Phase 3 | |
| Completed |
NCT03331263 -
Single Dose CHG Pharmacokinetic Study
|
Phase 1 | |
| Completed |
NCT02831816 -
Clinical Evaluation of Patient Preoperative Prep
|
Phase 3 |